Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma-a “real world” study

2017 ◽  
Vol 35 (4) ◽  
pp. 528-535 ◽  
Author(s):  
Narendranath Epperla ◽  
Mehdi Hamadani ◽  
Amanda F. Cashen ◽  
Kwang W. Ahn ◽  
Eunhye Oak ◽  
...  
Keyword(s):  
Mantle Cell Lymphoma ◽  
Predictive Factors ◽  
Real World ◽  
Cell Lymphoma ◽  
Mantle Cell

scholarly journals Erratum on “Non-indolent mantle cell lymphoma at a single public hospital in Brazil: real world first-line treatment cohort study data”

2020 ◽  
Vol 42 (2) ◽  
pp. 194
Author(s):  
Sergio Augusto Buzian Brasil ◽  
Carolina Colaço ◽  
Tomas Barrese ◽  
Roberto P. Paes ◽  
Cristina Bortolheiro ◽  
...  
Keyword(s):  
Cohort Study ◽  
Mantle Cell Lymphoma ◽  
Real World ◽  
Public Hospital ◽  
Cell Lymphoma ◽  
Study Data ◽  
Line Treatment ◽  
First Line ◽  
Mantle Cell ◽  
First Line Treatment

Predictive factors for blastoid transformation in the common variant of mantle cell lymphoma

2003 ◽  
Vol 39 (3) ◽  
pp. 321-329 ◽  
Author(s):  
R Räty ◽  
K Franssila ◽  
S.-E Jansson ◽  
H Joensuu ◽  
U Wartiovaara-Kautto ◽  
...  
Keyword(s):  
Mantle Cell Lymphoma ◽  
Predictive Factors ◽  
Cell Lymphoma ◽  
Common Variant ◽  
Mantle Cell ◽  
The Common

scholarly journals Survival in mantle cell lymphoma after frontline treatment with Rbendamustine, R-CHOP and the Nordic MCL2 regimen – a real world study on patients diagnosed in Sweden 2007-2017

Haematologica ◽  
2021 ◽  
Author(s):  
Alexandra Albertsson-Lindblad ◽  
Thorgerdur Palsdottir ◽  
Karin E. Smedby ◽  
Caroline E. Weibull ◽  
Ingrid Glimelius ◽  
...  
Keyword(s):  
Mantle Cell Lymphoma ◽  
Real World ◽  
Cell Lymphoma ◽  
Mantle Cell ◽  
Frontline Treatment

Not available.

Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory (R/R) mantle cell lymphoma (MCL).

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 7544-7544
Author(s):  
Narendranath Epperla ◽  
Mehdi Hamadani ◽  
Kwang Woo Ahn ◽  
Eunhye Oak ◽  
Amanda F. Cashen ◽  
...  
Keyword(s):  
Mantle Cell Lymphoma ◽  
Predictive Factors ◽  
Cell Lymphoma ◽  
Mantle Cell

scholarly journals Clinical outcomes for ibrutinib in relapsed or refractory mantle cell lymphoma in real‐world experience

2019 ◽  
Vol 8 (16) ◽  
pp. 6860-6870 ◽  
Author(s):  
Young‐Woo Jeon ◽  
Seugyun Yoon ◽  
Gi June Min ◽  
Sung‐Soo Park ◽  
Silvia Park ◽  
...  
Keyword(s):  
Mantle Cell Lymphoma ◽  
Clinical Outcomes ◽  
Real World ◽  
Cell Lymphoma ◽  
Mantle Cell
Sign in / Sign up

Export Citation Format

Share Document